What disease-extent imaging actually answers
When a clinician talks about disease extent, the practical question is simple: where has the cancer been found, and how far has it spread from where it started? Imaging such as CT, MRI, PET-CT or ultrasound is one part of answering that. A biopsy or surgical specimen examined by a pathologist is another. Blood tests, physical examination and the patient's history can also contribute.
The National Cancer Institute explains that cancer stage describes the extent of disease, and that staging approaches differ between cancer types. That last point matters for an overseas patient. There is no single universal imaging checklist that applies to every cancer. A staging review for a lung cancer, a lymphoma and a breast cancer will not look the same, and the imaging that is useful in one may be irrelevant in another.
This is why a staging review is not simply a request for more scans. It is a structured look at what is already known, what the images and pathology reports actually show, and what gaps remain before treatment options can be discussed sensibly.
Why imaging alone does not complete a stage
A common misunderstanding is that a scan report equals a stage. It does not. Stage is a summary judgement that draws on imaging, pathology, clinical findings and sometimes molecular information, and the relative weight of each depends on the cancer type. A radiology report may describe a mass, its size, its relationship to nearby structures and whether distant sites appear involved. A pathology report describes what the tissue actually is. Neither replaces the other.
The NCI source also distinguishes stage from grade, which is a separate concept describing how abnormal the cancer cells look under a microscope. Patients sometimes use the two words interchangeably, and that can create confusion when records are sent abroad. If your documents use stage and grade, it helps to keep them clearly separated when you summarise your case.
For a China staging review, the value of sending both imaging and pathology is that the reviewing clinician can see whether the two are consistent, whether anything is missing, and whether the existing studies are recent and technically adequate for the question being asked. That is a records-based assessment, not a diagnosis made from a distance.
What to send for a staging review
The most useful starting point is not a complete archive but a clear, organised summary. Begin with a short written history: when the cancer was first suspected or diagnosed, what treatment has already been given, and what the main question is now. Then list the studies you have, with dates and the body area covered.
Imaging is more useful when the reviewing team can see the actual images, not only the written report. If you have discs or a secure link to the original CT, MRI or PET-CT files, ask whether those can be reviewed. Reports alone can answer some questions but not all, particularly when a lesion's size or location is being assessed.
Pathology slides or blocks may also be requested if a re-review is needed. Whether that is necessary depends on the cancer type and the question being asked, so it is reasonable to ask the receiving team what they would want before you arrange international shipping of physical materials.
A practical checklist for your first message: a one-page summary of the diagnosis and treatment so far; a list of imaging studies with dates; the corresponding radiology reports; the pathology report; and your single most important question. Keep the first contact brief. Detailed records can follow once the team confirms what it needs.
The question of further imaging before treatment planning
A frequent concern is whether more scans will be needed in China before treatment can be planned. That is not something an article can answer for an individual, because it depends on the cancer type, what has already been done, how recent the studies are, and what the treating team needs to see. It is a question to put directly to the clinical team.
It helps to ask it in a specific way. Instead of asking whether more tests are needed, ask which existing studies can be reviewed as they are, and whether any further investigation would be required before treatment planning could proceed. That phrasing gives the clinician something concrete to respond to.
It is also worth asking who would order any additional imaging, where it would be performed, and how the results would be incorporated into the plan. These are administrative and clinical questions that belong to the treating hospital, not to a coordination service.
One boundary is important. A records-based review can clarify what the existing evidence shows and what remains uncertain. It does not establish that a particular treatment is available, that a hospital will accept the case, or that travel is appropriate. Those decisions rest with the treating clinicians and the hospital.
How staging connects to treatment discussions
Stage is used to help inform treatment discussions. It is not a treatment plan by itself, and it does not determine a single correct option. Two patients with the same stage of the same cancer can still receive different recommendations because of age, general health, prior treatment, molecular findings and personal priorities.
This is why a staging review is often most useful as preparation for a conversation rather than as a final answer. If the extent of disease is unclear or the existing studies are incomplete, the treatment discussion may be premature. Clarifying the stage can change which options are worth discussing.
For an overseas patient, there is an additional practical layer. Even a well-established stage does not tell you whether care in China is suitable for your situation, how long a visit might take, or what it would involve. Those are separate questions that need to be raised with the hospital and with any coordination service you use.
It can help to write down, before any appointment, the two or three decisions you are actually trying to make. That keeps the staging review focused on the information that would change those decisions.
Coordinating a staging review from abroad
ChinaSpecialistCare provides non-clinical coordination for international patients, including help organising a records-based staging review with a suitable hospital team. The clinical assessment itself belongs to the treating hospital and its licensed clinicians. Our role is administrative: helping gather and transmit records, arranging appointments, and supporting communication.
An initial enquiry is free and does not require buying a proxy consultation. You can start with a brief summary of the diagnosis and your main question. If a records-based specialist opinion is appropriate, that can be discussed separately, and it remains optional rather than a prerequisite for every appointment.
If you would like to begin, send a short summary through the enquiry form, email or WhatsApp. Include the cancer type if known, the date of diagnosis, the imaging and pathology you already have, and the one question you most want answered. The team can then explain what information would help and what the next practical step would be.
For more detail on how a staging review is organised, see the related page on cancer staging review.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.